ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship

October 2, 1992

NCI-Approved Clinical Trials

September 28, 2001

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

Other NCI funding opportunities listed.

July 9, 2004